Soluble in DMSO (up to 30 mg/ml) or in DMF (up to 50 mg/ml).
Apariencia
White or off-white solid
Condiciones de almacenamiento
-20°C
Indicación
Anti-cancer
Descripción del Producto
Baricitinib (1187594-09-7), approved by the FDA for two inflammatory disorders, rheumatoid arthritis and alopecia areata, selectively inhibits Janus kinase 1 (IC50?= 5.9 nM) and 2 (5.7 nM), over 3 (0.56 μM).1
